Evidence map›Paper›PMID 35536732›Full record

ArticleAmerican journal of respiratory and critical care medicine2022

Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary Disease.

Siddharth S Madapoosi, Charmion Cruickshank-Quinn, Kristopher Opron, John R Erb-Downward, Lesa A Begley, Gen Li, Igor Barjaktarevic, R Graham Barr, Alejandro P Comellas, David J Couper and 18 more

Erratum issued Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in American journal of respiratory and critical care medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT01969344 (Subpopulations and Intermediate Outcome Measures in COPD Study), which is not on this map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01969344 active not recruitingnot on this map

Subpopulations and Intermediate Outcome Measures in COPD Study

TypeobservationalSponsorUniversity of North Carolina, Chapel HillRan2010 to 2031Enrolled2,981ConditionsCOPD, Chronic Obstructive Pulmonary Disease, Chronic Bronchitis, Emphysema
3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 89 citations in OpenAlex.

  1. Journal of bacteriology · 2026
    Review
  2. Review
  3. The redefined identity ofJournal of bacteriology · 2026
    Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Why the COPD Microbiome Matters: How Airway Microbes Shape Disease Severity and Treatment Response.International journal of chronic obstructive pulmonary disease · 2026
    Review
  12. Review
  13. Multi-omics to study chronic respiratory diseases and viral infections.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. iScience · 2025
    Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors at 15 institutions in 2 countries.

Siddharth S MadapoosiDivision of Pulmonary and Critical Care Medicine, Department of Medicine.
Charmion Cruickshank-QuinnDepartment of Pharmaceutical Sciences, University of Colorado, Anschutz Campus, Aurora, Colorado.
Kristopher OpronDivision of Pulmonary and Critical Care Medicine, Department of Medicine.
John R Erb-DownwardDivision of Pulmonary and Critical Care Medicine, Department of Medicine.
Lesa A BegleyDivision of Pulmonary and Critical Care Medicine, Department of Medicine.
Gen LiDepartment of Biostatistics, School of Public Health.
Igor BarjaktarevicUniversity of California at Los Angeles, Los Angeles, California.
R Graham BarrDepartment of Medicine and.
Alejandro P ComellasUniversity of Iowa, Iowa City, Iowa.ORCID 0000-0003-1521-7520
David J CouperDepartment of Biostatistics.
Christopher B CooperUniversity of California at Los Angeles, Los Angeles, California.
Christine M FreemanDivision of Pulmonary and Critical Care Medicine, Department of Medicine.
MeiLan K HanDivision of Pulmonary and Critical Care Medicine, Department of Medicine.
Robert J KanerWeill Cornell Medical College, New York, New York.
Wassim LabakiDivision of Pulmonary and Critical Care Medicine, Department of Medicine.
Fernando J MartinezWeill Cornell Medical College, New York, New York.
Victor E OrtegaWake Forest School of Medicine, Wake Forest University, Winston-Salem, North Carolina.
Stephen P PetersWake Forest School of Medicine, Wake Forest University, Winston-Salem, North Carolina.
Robert PaineUniversity of Utah, Salt Lake City, Utah.
Prescott WoodruffUniversity of California at San Francisco, San Francisco, California.
Jeffrey L CurtisDivision of Pulmonary and Critical Care Medicine, Department of Medicine.ORCID 0000-0001-5191-4847
Gary B HuffnagleDivision of Pulmonary and Critical Care Medicine, Department of Medicine.
Kathleen A StringerDepartment of Clinical Pharmacy, College of Pharmacy, and.ORCID 0000-0003-0238-7774
Russell P BowlerSchool of Medicine, University of Colorado, Aurora, Colorado; and.
Charles R EstherDivision of Pediatric Pulmonology, and.
Nichole ReisdorphDepartment of Pharmaceutical Sciences, University of Colorado, Anschutz Campus, Aurora, Colorado.
Yvonne J HuangDivision of Pulmonary and Critical Care Medicine, Department of Medicine.ORCID 0000-0002-7497-6597
SPIROMICS Research Group
Pulmonary and Critical Care Associates · USCornell University · USUniversity of California, Los Angeles · USUniversity of Colorado Anschutz Medical Campus · USWake Forest University · USCancer Research And Biostatistics · USColumbia University Irving Medical Center · USInstitut thématique Génétique, génomique et bioinformatique · FRNational Jewish Health · USUniversity of California, San Francisco · USUniversity of Iowa · USUniversity of Michigan · USUniversity of North Carolina at Chapel Hill · USUniversity of Utah · USVA Ann Arbor Healthcare System · US

Funding

Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Jong Sung Kim · 1990 to 2026
$40.5M
SPIROMICS II: Biological underpinnings of COPD heterogeneity and progressionU01HL137880 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WOODRUFF, PRESCOTT G · 2017 to 2021
$27.9M
SPIROMICS GIC SupportU24HL141762 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COUPER, DAVID J, O'NEAL, WANDA K · 2018 to 2022
$7.2M
Sputum Microbial Markers of Type 2-Low AsthmaR01AI129958 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HUANG, YVONNE JEAN · 2017 to 2021
$3.6M
Functional Analysis of the Pulmonary Microbiome during COPDR01HL121774 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HUFFNAGLE, GARY B · 2017 to 2020
$3.1M
NHLBI NIH HHS HHSN268200900013CNHLBI NIH HHS HHSN268200900014CNHLBI NIH HHS HHSN268200900015CNHLBI NIH HHS HHSN268200900016CNHLBI NIH HHS HHSN268200900017CNHLBI NIH HHS HHSN268200900018CNHLBI NIH HHS HHSN268200900019CNHLBI NIH HHS HHSN268200900020CNHLBI NIH HHS R01 HL121774NHLBI NIH HHS R01HL121774NHLBI NIH HHS R01HL121774-S1NHLBI NIH HHS U01 HL137880NHLBI NIH HHS U24 HL141762NIAID NIH HHS R01 AI129958NIEHS NIH HHS P30 ES005605
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MicrobiotaPulmonary Disease, Chronic ObstructiveAdenosineHumansLungRNA, Ribosomal, 16SAdenosineRNA, Ribosomal, 16Sbronchoscopychronic obstructive pulmonary diseaselung functionmetabolomics

Identifiers

PMID35536732
PMCPMC11418810
OpenAlexW4280506158

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.